Discovery of PF-06928215 as a high affinity inhibitor of cGAS enabled by a novel fluorescence polarization assay
- Pfizer, Groton, CT (United States)
- Pfizer Centers for Therapeutic Innovation (CTI), Boston, MA (United States)
- Pfizer Centers for Therapeutic Innovation (CTI), San Diego, CA (United States)
- Pfizer, Cambridge, MA (United States)
- Univ. of Massachusetts Medical School, Worcester, MA (United States)
- Univ. of Massachusetts Medical School, Worcester, MA (United States); Univ. Hospitals Bonn (Germany)
- Toho Daigaku (Japan)
Cyclic GMP-AMP synthase (cGAS) initiates the innate immune system in response to cytosolic dsDNA. After binding and activation from dsDNA, cGAS uses ATP and GTP to synthesize 2', 3' -cGAMP (cGAMP), a cyclic dinucleotide second messenger with mixed 2'-5' and 3'-5' phosphodiester bonds. Inappropriate stimulation of cGAS has been implicated in autoimmune disease such as systemic lupus erythematosus, thus inhibition of cGAS may be of therapeutic benefit in some diseases; however, the size and polarity of the cGAS active site makes it a challenging target for the development of conventional substrate-competitive inhibitors. We report here the development of a high affinity (KD = 200 nM) inhibitor from a low affinity fragment hit with supporting biochemical and structural data showing these molecules bind to the cGAS active site. We also report a new high throughput cGAS fluorescence polarization (FP)-based assay to enable the rapid identification and optimization of cGAS inhibitors. This FP assay uses Cy5-labelled cGAMP in combination with a novel high affinity monoclonal antibody that specifically recognizes cGAMP with no cross reactivity to cAMP, cGMP, ATP, or GTP. Given its role in the innate immune response, cGAS is a promising therapeutic target for autoinflammatory disease. Our results demonstrate its druggability, provide a high affinity tool compound, and establish a high throughput assay for the identification of next generation cGAS inhibitors.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States)
- Sponsoring Organization:
- USDOE
- OSTI ID:
- 1405009
- Journal Information:
- PLoS ONE, Journal Name: PLoS ONE Journal Issue: 9 Vol. 12; ISSN 1932-6203
- Publisher:
- Public Library of ScienceCopyright Statement
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Viral and metazoan poxins are cGAMP-specific nucleases that restrict cGAS-STING signalling
cGAS-like receptors sense RNA and control 3'2'-cGAMP signalling in Drosophila